
Michael D. Pak
Examiner (ID: 450, Phone: (571)272-0879 , Office: P/1646 )
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1674, 1812, 0, 1646, 1621 |
| Total Applications | 1542 |
| Issued Applications | 712 |
| Pending Applications | 275 |
| Abandoned Applications | 568 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14456277
[patent_doc_number] => 10324095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Methods for diagnosing osteoarthritis
[patent_app_type] => utility
[patent_app_number] => 15/158689
[patent_app_country] => US
[patent_app_date] => 2016-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 40
[patent_no_of_words] => 18792
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158689
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/158689 | Methods for diagnosing osteoarthritis | May 18, 2016 | Issued |
Array
(
[id] => 14485175
[patent_doc_number] => 10329355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Compositions and methods for targeting stromal cells for the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 15/158727
[patent_app_country] => US
[patent_app_date] => 2016-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 36000
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/158727 | Compositions and methods for targeting stromal cells for the treatment of cancer | May 18, 2016 | Issued |
Array
(
[id] => 11491382
[patent_doc_number] => 20170065568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'METHODS AND COMPOUNDS FOR CALCIUM ION CHANNEL REGULATION'
[patent_app_type] => utility
[patent_app_number] => 15/154140
[patent_app_country] => US
[patent_app_date] => 2016-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7067
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15154140
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/154140 | METHODS AND COMPOUNDS FOR CALCIUM ION CHANNEL REGULATION | May 12, 2016 | Abandoned |
Array
(
[id] => 11107632
[patent_doc_number] => 20160304603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'METHODS FOR MODULATING MANNOSE CONTENT OF RECOMBINANT PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/150627
[patent_app_country] => US
[patent_app_date] => 2016-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16595
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15150627
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/150627 | Methods for modulating mannose content of recombinant proteins | May 9, 2016 | Issued |
Array
(
[id] => 11123427
[patent_doc_number] => 20160320401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'METHOD AND APPARATUS FOR SIGNAL TRANSDUCTION PATHWAY PROFILING'
[patent_app_type] => utility
[patent_app_number] => 15/149843
[patent_app_country] => US
[patent_app_date] => 2016-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7213
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15149843
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/149843 | METHOD AND APPARATUS FOR SIGNAL TRANSDUCTION PATHWAY PROFILING | May 8, 2016 | Abandoned |
Array
(
[id] => 11123440
[patent_doc_number] => 20160320414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'Assay for Detection of Transient Intracellular CA2+'
[patent_app_type] => utility
[patent_app_number] => 15/147326
[patent_app_country] => US
[patent_app_date] => 2016-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 7144
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15147326
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/147326 | Assay for Detection of Transient Intracellular CA2+ | May 4, 2016 | Abandoned |
Array
(
[id] => 18154098
[patent_doc_number] => 11567073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Receptor tyrosine kinase biomarkers
[patent_app_type] => utility
[patent_app_number] => 15/569871
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 4
[patent_no_of_words] => 12776
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569871
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569871 | Receptor tyrosine kinase biomarkers | Apr 27, 2016 | Issued |
Array
(
[id] => 13590063
[patent_doc_number] => 20180346580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => Antibodies to Canine Interleukin-4 Receptor Alpha
[patent_app_type] => utility
[patent_app_number] => 15/562308
[patent_app_country] => US
[patent_app_date] => 2016-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562308
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/562308 | Antibodies to canine interleukin-4 receptor alpha | Mar 31, 2016 | Issued |
Array
(
[id] => 13593365
[patent_doc_number] => 20180348231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => LIGAND INDUCIBLE POLYPEPTIDE COUPLER SYSTEM
[patent_app_type] => utility
[patent_app_number] => 15/562290
[patent_app_country] => US
[patent_app_date] => 2016-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562290
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/562290 | LIGAND INDUCIBLE POLYPEPTIDE COUPLER SYSTEM | Mar 28, 2016 | Abandoned |
Array
(
[id] => 13548781
[patent_doc_number] => 20180325938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => METHOD OF EVALUATING OR SELECTING ANDROGEN RECEPTOR ACTIVITY REGULATOR SELECTIVE TO SEBACEOUS GLANDS OR HAIR FOLLICLES
[patent_app_type] => utility
[patent_app_number] => 15/531636
[patent_app_country] => US
[patent_app_date] => 2016-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531636
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/531636 | METHOD OF EVALUATING OR SELECTING ANDROGEN RECEPTOR ACTIVITY REGULATOR SELECTIVE TO SEBACEOUS GLANDS OR HAIR FOLLICLES | Mar 24, 2016 | Abandoned |
| 15/068412 | RANDOM CONJUGATE MOLECULE AND METHODS OF MAKING AND USING THE SAME | Mar 10, 2016 | Abandoned |
Array
(
[id] => 17526859
[patent_doc_number] => 11299531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Fusion protein comprising a ligand binding domain of VEGF and PDGF
[patent_app_type] => utility
[patent_app_number] => 15/542692
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 14848
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542692
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542692 | Fusion protein comprising a ligand binding domain of VEGF and PDGF | Mar 9, 2016 | Issued |
Array
(
[id] => 12707011
[patent_doc_number] => 20180127503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => Anti-ROR2 Antibodies
[patent_app_type] => utility
[patent_app_number] => 15/555036
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555036
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555036 | Anti-ROR2 antibodies | Mar 9, 2016 | Issued |
Array
(
[id] => 12425013
[patent_doc_number] => 09974842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-22
[patent_title] => Inotropic antibodies and therapeutic uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/062329
[patent_app_country] => US
[patent_app_date] => 2016-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 14436
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15062329
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/062329 | Inotropic antibodies and therapeutic uses thereof | Mar 6, 2016 | Issued |
Array
(
[id] => 13389079
[patent_doc_number] => 20180246082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => ASSAY TO DIAGNOSE AND TREAT DISORDERS OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION
[patent_app_type] => utility
[patent_app_number] => 15/553826
[patent_app_country] => US
[patent_app_date] => 2016-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553826
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/553826 | Assay to diagnose and treat disorders of the alternative pathway of complement activation | Feb 28, 2016 | Issued |
Array
(
[id] => 10981690
[patent_doc_number] => 20160178635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'Human cellular models with biosensors'
[patent_app_type] => utility
[patent_app_number] => 15/055202
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9821
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15055202
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/055202 | Human cellular models with biosensors | Feb 25, 2016 | Issued |
Array
(
[id] => 12158834
[patent_doc_number] => 20180030100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'NON-NATURAL SEMAPHORINS 3 AND THEIR MEDICAL USE'
[patent_app_type] => utility
[patent_app_number] => 15/552511
[patent_app_country] => US
[patent_app_date] => 2016-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 57490
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552511
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/552511 | Non-natural Semaphorins 3 and their medical use | Feb 22, 2016 | Issued |
Array
(
[id] => 13814437
[patent_doc_number] => 10183979
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-22
[patent_title] => Fusion polypeptides comprising mucin-domain polypeptide linkers
[patent_app_type] => utility
[patent_app_number] => 15/044310
[patent_app_country] => US
[patent_app_date] => 2016-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17766
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15044310
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/044310 | Fusion polypeptides comprising mucin-domain polypeptide linkers | Feb 15, 2016 | Issued |
Array
(
[id] => 10791572
[patent_doc_number] => 20160137728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'ANTIBODY SPECIFICALLY BINDING TO INSULIN-LIKE GROWTH FACTOR-1'
[patent_app_type] => utility
[patent_app_number] => 15/003988
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14705
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15003988
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/003988 | Antibody specifically binding to insulin-like growth factor-1 | Jan 21, 2016 | Issued |
Array
(
[id] => 12185461
[patent_doc_number] => 20180044397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'MINIMALLY-INVASIVE AND ACTIVITY-DEPENDENT CONTROL OF EXCITABLE CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/545428
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17410
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545428
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545428 | Minimally-invasive and activity-dependent control of excitable cells | Jan 21, 2016 | Issued |